VRCA
Verrica Pharmaceuticals Inc
4.40$
-3.0%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | -251.7% | -229.9% | -206.5% | -752.9% | -805.3% | -49.5% | |
| – | – | – | – | 1.9% | 3.9% | 7.9% | 16.3% | 16.8% | 1.2% | |
| – | – | – | – | 81.8% | 50.4% | 55.2% | 280.6% | 94.7% | 9.3% | |
| – | – | – | – | 88.5% | 62.5% | 75.3% | – | – | – | |
| – | – | – | – | 13.6% | -4.5% | -19.9% | 192.4% | 26.8% | -17.6% | |
| – | – | – | – | 12.3% | 7.4% | 3.3% | 7.1% | 0.4% | 0.0% | |
| – | – | – | – | -29.8% | -8.3% | 598.3% | -7.1% | -0.3% | – | |
| – | – | – | – | 3.8% | 239.0% | 297.8% | – | – | – | |
| – | – | – | – | 287.2% | 41.5% | -484.6% | 860.3% | -27.3% | -135.5% | |
| – | – | – | – | 293.6% | 280.4% | -186.8% | 1,448.3% | 498.7% | 4.1% | |
| – | – | – | – | 12.0% | 42.2% | 205.1% | 688.4% | -306.9% | -45.5% | |
| – | – | – | – | -264.0% | -237.2% | -209.8% | -759.9% | -805.6% | -49.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.